Top Updates 戻る
CSL Behring
CSL Behring's Parent Company 別名
CSL (CSL Behring's Parent Company) 別名
Australia
Immunology
Hematology
Cardiovascular and Metabolic
Respiratory
Transplant
Plasma Fractionation
Recombinant Protein Technology
Cell and Gene Therapy
Development and delivery of innovative medicines for bleeding disorders
Treatment of immune deficiencies
Treatment of chronic inflammatory demyelinating polyneuropathy
Treatment of hereditary angioedema
Treatment of Alpha 1 Antitrypsin Deficiency
Biotherapy products for rare diseases
Melbourne, Australia
32,000 人
会社名
Group 親会社 子会社 得意先 仕入先 業務提携 銀行等 株主等
CSL Seqirus
グループ会社 親会社 子会社 得意先 仕入先 業務提携 銀行・融資・与信 出資・持分・株主
Group 子会社
CSL Vifor
グループ会社 親会社 子会社 得意先 仕入先 業務提携 銀行・融資・与信 出資・持分・株主
Group 子会社

2 件
日付概要
2023-04-07 Staff who work at the CSL Behring location were first to donate during the soft opening.
2023-04-10 The new center will open to the public April 10 and has been outfitted with new donation technology designed for quicker collection times.
+ 開くと読み込みます
✅
2026-08-05 14:23 (Model: ggml-org/gpt-oss-20b )
↑